GLP-1 Drugs Now Start as Low as $149 — But There’s a Catch

Wegovy’s advertised $149 monthly price applies to its 1.5-milligram pill, while higher doses and injectable options cost more. Patients should compare ongoing prescription costs, insurance eligibility, and discount restrictions before starting treatment. Photo Nature Travel/Shutterstock

For Americans who have been priced out of popular weight-loss medications, a $149 monthly price tag sounds like welcome news. After years of seeing drugs such as Wegovy and Zepbound carry substantial out-of-pocket costs, manufacturers are offering new ways for eligible patients to access treatment at lower prices.

But there’s something important hiding behind that $149 figure. The advertised GLP-1 drug prices don’t necessarily apply to every medication, dosage, or patient, and some introductory offers become considerably more expensive after the first few months. For someone living on a fixed income or carefully managing healthcare expenses, misunderstanding those details could turn an affordable treatment into a significant financial commitment.